Literature DB >> 35596047

Blood Pressure Assessment and Treatment in the Observation Unit.

Christina M Vitto1, Joseph D Lykins V2, Hillary Wiles-Lafayette2, Taruna K Aurora2.   

Abstract

PURPOSE OF REVIEW: To review the pathophysiology, diagnosis, and the management of hypertension. Given the paucity of literature regarding the role of the observation unit in the management of hypertension, we will provide our recommendations based on our experience working in an observation unit. RECENT
FINDINGS: Many patients have limited access to primary care, and hypertension diagnosis often relies on office-based measurements. We will describe situations where that is not necessary to make the diagnosis. We will discuss the current non-pharmacologic treatment guidelines, the education of which should be provided to patients both in the emergency department and observation units. We will provide the current recommendations on what anti-hypertension medications can be initiated in the emergency department and observation units. Hypertension is a leading cause of morbidity and mortality in the USA. The utility of an observation unit in the diagnosis and management of patients with hypertension is beneficial particularly for those with risk factors for atherosclerotic disease. An observation unit stay provides the opportunity to diagnosis hypertension, initiate lifestyle education and pharmacologic treatment if indicated, and help to arrange appropriate follow-up for ongoing management and treatment in individuals with limited access to care.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Blood pressure; Emergency department; Hypertension; Observation unit

Mesh:

Substances:

Year:  2022        PMID: 35596047     DOI: 10.1007/s11906-022-01196-3

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   4.592


  42 in total

Review 1.  Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension.

Authors:  Alan Morrison; Dena Rosen Ramey; Janet van Adelsberg; Douglas J Watson
Journal:  Curr Med Res Opin       Date:  2007-10       Impact factor: 2.580

2.  Circadian blood pressure rhythm and atrial natriuretic peptide in prednisolone-induced blood pressure elevation.

Authors:  P Ivarsen; L W Jensen; E B Pedersen
Journal:  Scand J Clin Lab Invest       Date:  1995-12       Impact factor: 1.713

Review 3.  Implementing ABPM into Clinical Practice.

Authors:  Alan L Hinderliter; Raven A Voora; Anthony J Viera
Journal:  Curr Hypertens Rep       Date:  2018-02-05       Impact factor: 5.369

4.  Harmful effects of NSAIDs among patients with hypertension and coronary artery disease.

Authors:  Anthony A Bavry; Asma Khaliq; Yan Gong; Eileen M Handberg; Rhonda M Cooper-Dehoff; Carl J Pepine
Journal:  Am J Med       Date:  2011-05-18       Impact factor: 4.965

5.  Utility of routine testing for patients with asymptomatic severe blood pressure elevation in the emergency department.

Authors:  David J Karras; Linda K Kruus; John J Cienki; Marlena M Wald; Jacob W Ufberg; Philip Shayne; David A Wald; Katherine L Heilpern
Journal:  Ann Emerg Med       Date:  2007-05-11       Impact factor: 5.721

Review 6.  Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice: A Narrative Review.

Authors:  Daichi Shimbo; Marwah Abdalla; Louise Falzon; Raymond R Townsend; Paul Muntner
Journal:  Ann Intern Med       Date:  2015-10-13       Impact factor: 25.391

7.  Incidence of Hypertension-Related Emergency Department Visits in the United States, 2006 to 2012.

Authors:  Candace D McNaughton; Wesley H Self; Yuwei Zhu; Alexander T Janke; Alan B Storrow; Phillip Levy
Journal:  Am J Cardiol       Date:  2015-09-10       Impact factor: 2.778

8.  Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population.

Authors:  S Shea; D Misra; M H Ehrlich; L Field; C K Francis
Journal:  N Engl J Med       Date:  1992-09-10       Impact factor: 91.245

9.  Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion.

Authors:  L Fardet; A Flahault; A Kettaneh; K P Tiev; T Généreau; C Tolédano; C Lebbé; J Cabane
Journal:  Br J Dermatol       Date:  2007-05-14       Impact factor: 9.302

10.  Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension.

Authors:  Hisham Aljadhey; Wanzhu Tu; Richard A Hansen; Susan J Blalock; D Craig Brater; Michael D Murray
Journal:  BMC Cardiovasc Disord       Date:  2012-10-24       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.